Literature DB >> 12442672

Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies.

Caroline M Tanner1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12442672

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  41 in total

1.  Head injury at early ages is associated with risk of Parkinson's disease.

Authors:  Kathryn M Taylor; Marie-Helene Saint-Hilaire; Lewis Sudarsky; David K Simon; Bonnie Hersh; David Sparrow; Howard Hu; Marc G Weisskopf
Journal:  Parkinsonism Relat Disord       Date:  2015-12-19       Impact factor: 4.891

2.  The association between Mediterranean diet adherence and Parkinson's disease.

Authors:  Roy N Alcalay; Yian Gu; Helen Mejia-Santana; Lucien Cote; Karen S Marder; Nikolaos Scarmeas
Journal:  Mov Disord       Date:  2012-02-07       Impact factor: 10.338

Review 3.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

4.  Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease.

Authors:  Xuemei Huang; Honglei Chen; William C Miller; Richard B Mailman; Jennifer L Woodard; Peter C Chen; Dong Xiang; Richard W Murrow; Yi-Zhe Wang; Charles Poole
Journal:  Mov Disord       Date:  2007-02-15       Impact factor: 10.338

Review 5.  Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.

Authors:  Li Qian; Patrick M Flood; Jau-Shyong Hong
Journal:  J Neural Transm (Vienna)       Date:  2010-06-23       Impact factor: 3.575

6.  Lrrk2 pathogenic substitutions in Parkinson's disease.

Authors:  Ignacio F Mata; Jennifer M Kachergus; Julie P Taylor; Sarah Lincoln; Jan Aasly; Timothy Lynch; Mary M Hulihan; Stephanie A Cobb; Ruey-Meei Wu; Chin-Song Lu; Carlos Lahoz; Zbigniew K Wszolek; Matthew J Farrer
Journal:  Neurogenetics       Date:  2005-09-17       Impact factor: 2.660

7.  Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.

Authors:  Edna Grünblatt; Josefine Ruder; Camelia Maria Monoranu; Peter Riederer; Moussa Bh Youdim; Silvia A Mandel
Journal:  Neurotox Res       Date:  2017-12-07       Impact factor: 3.911

8.  Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease.

Authors:  J A Morales-García; C Susín; S Alonso-Gil; D I Pérez; V Palomo; C Pérez; S Conde; A Santos; C Gil; A Martínez; A Pérez-Castillo
Journal:  ACS Chem Neurosci       Date:  2012-12-05       Impact factor: 4.418

Review 9.  Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.

Authors:  Vladimir N Uversky; David Eliezer
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

Review 10.  Disease-Toxicant Interactions in Parkinson's Disease Neuropathology.

Authors:  Gunnar F Kwakye; Rachael A McMinimy; Michael Aschner
Journal:  Neurochem Res       Date:  2016-09-09       Impact factor: 3.996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.